Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part

被引：2
|
作者：
Hebbar, M. [1 ]
Heurgue-Berlot, A. [2 ]
Boige, V. [3 ]
Le Malicot, K. [4 ]
Bernard-Chabert, B. [2 ]
Marcus, C. [5 ]
Dharancy, S. [6 ]
Sergent, G. [7 ]
Perarnau, J. M. [8 ]
Ehrhard, F. [9 ]
Ollivier-Hourmand, I. [10 ]
Vergniol, J. [11 ]
Michel, P. [12 ]
Edeline, J. [13 ]
Rinaldi, Y. [14 ]
Seitz, J. F. [15 ]
Lepage, C. [16 ]
De Baere, T. [17 ]
机构：
[1] Ctr Hosp Huriez, Med Oncol, Lille, France
[2] Univ Hosp, Hepatol, Reims, France
[3] Gustave Roussy, Digest Oncol, Villejuif, France
[4] Federat Francophone Cancerol Digest, Biostat, Dijon, France
[5] Univ Hosp, Radiol, Reims, France
[6] Ctr Hosp Huriez, Hepatol, Lille, France
[7] Ctr Hosp Huriez, Radiol, Lille, France
[8] Univ Hosp, Gastroenterol, Tours, France
[9] Univ Hosp, Gastroenterol, Reims, France
[10] Univ Hosp, Gastroenterol, Caen, France
[11] Univ Hosp, Gastroenterol, Pessac, France
[12] Univ Hosp, Gastroenterol, Rouen, France
[13] Anticanc Ctr, Oncol, Rennes, France
[14] Hop Ambroise Pare, Gastroenterol, Marseille, France
[15] La Timone Univ Hosp, Digest Oncol, Marseille, France
[16] Univ Hosp, Gastroenterol, Dijon, France
[17] Gustave Roussy, Radiol, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31221-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2305
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
    Bruix, J.
    Merle, P.
    Granito, A.
    Huang, Y. -H.
    Bodoky, G.
    Yokosuka, O.
    Rosmorduc, O.
    Breder, V.
    Gerolami, R.
    Masi, G.
    Paul, J. Ross
    Qin, S.
    Song, T.
    Bronowicki, J. -P.
    Ollivier-Hourmand, I.
    Kudo, M.
    LeBerre, M. -A.
    Baumhauer, A.
    Meinhardt, G.
    Han, G.
    ANNALS OF ONCOLOGY, 2016, 27 : 140 - +
  • [42] Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): Insights from a multidisciplinary phase II study
    Zhu, A. X.
    Sahani, D. V.
    di Tomaso, E.
    Duda, D. G.
    Catalano, O. A.
    Ancukiewicz, M.
    Blaszkowsky, L. S.
    Abrams, T. A.
    Ryan, D. P.
    Jain, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background
    Meyer, Tim
    Fox, Richard
    Ma, Yuk Ting
    Ross, Paul J.
    James, Martin
    Strugess, Richard
    Stubbs, Clive
    Wall, Lucy
    Watkinson, Anthony
    Hacking, Nigel
    Evans, T. R. Jeffry
    Collins, Peter
    Hubner, Richard
    Cunningham, David
    Primrose, John Neil
    Johnson, Philip James
    Palmer, Daniel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Phase I/II study of a fine-powder formulation of cisplatin for transcatheter arterial chemoembolization in hepatocellular carcinoma
    Moriguchi, Masamichi
    Takayama, Tadatoshi
    Nakamura, Masahiko
    Aramaki, Osamu
    Higaki, Tokio
    Nakayama, Hisashi
    Ohkubo, Takao
    Fujii, Masashi
    HEPATOLOGY RESEARCH, 2010, 40 (04) : 369 - 375
  • [45] Trial in progress: neoadjuvant combination therapy of lenvatinib plus Transcatheter Arterial Chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma
    Abdelrahim, M.
    Esmail, A.
    Saharia, A.
    Connor, A.
    Kodali, S.
    Victor, D.
    Heyne, K.
    Moore, L.
    Ghobrial, R. M.
    TRANSPLANTATION, 2023, 107 (09) : 268 - 269
  • [46] Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma
    Abdelrahim, M.
    Esmail, A.
    Saharia, A.
    Kodali, S.
    Victor, D.
    Heyne, K.
    Ghobrial, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S307 - S307
  • [47] Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma
    Zhou, Bo
    Yan, Zhiping
    Liu, Rong
    Shi, Peng
    Qian, Sheng
    Qu, Xudong
    Zhu, Liang
    Zhang, Wei
    Wang, Jianhua
    RADIOLOGY, 2016, 280 (02) : 630 - 639
  • [48] Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Buijs, Manon
    Reyes, Diane K.
    Pawlik, Timothy M.
    Blackford, Amanda L.
    Salem, Riad
    Messersmith, Wells A.
    Weekes, Colin D.
    Mulcahy, Mary
    Kamel, Ihab R.
    Geschwind, Jean-Francois H.
    CANCER, 2013, 119 (05) : 1042 - 1049
  • [49] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF TSU-68 (ORANTINIB) COMBINED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Park, J. -W.
    Cheng, A. -L.
    Kudo, M.
    Park, J. H.
    Liang, P. -C.
    Hidaka, H.
    Izumi, N.
    Heo, J.
    Lee, Y. J.
    Sheen, I-S.
    Chiu, C. -F.
    Arioka, H.
    Morita, S.
    Arai, Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S189 - S190
  • [50] Phase I/II trial of continuous hepatic arterial infusion (HAI) of irinotecan in patients with hepatocellular carcinoma (HCC). Preliminary results
    Brandi, G.
    Derenzini, E.
    Pantaleo, M. A.
    Piscaglia, F.
    Golfieri, R.
    Bolondi, L.
    Mirarchi, M. G.
    Danesi, R.
    Biasco, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI50 - XI50
12345